Visintin A - Search Results

1

Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.

Altomonte M, Visintin A, Tecce R, Leonardi A, Calabro L, Fonsatti E, Pucillo C, Maio M. Altomonte M, et al. Among authors: visintin a. J Cell Physiol. 2004 Aug;200(2):272-6. doi: 10.1002/jcp.20015. J Cell Physiol. 2004. PMID: 15174097

2

Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?

Altomonte M, Fonsatti E, Visintin A, Maio M. Altomonte M, et al. Among authors: visintin a. Oncogene. 2003 Sep 29;22(42):6564-9. doi: 10.1038/sj.onc.1206960. Oncogene. 2003. PMID: 14528281 Review.

3

Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement.

Coral S, Fonsatti E, Sigalotti L, De Nardo C, Visintin A, Nardi G, Colizzi F, Colombo MP, Romano G, Altomonte M, Maio M. Coral S, et al. Among authors: visintin a. J Cell Physiol. 2000 Dec;185(3):317-23. doi: 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L. J Cell Physiol. 2000. PMID: 11056001

4

Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.

Brasoveanu LI, Fonsatti E, Visintin A, Pavlovic M, Cattarossi I, Colizzi F, Gasparollo A, Coral S, Horejsi V, Altomonte M, Maio M. Brasoveanu LI, et al. Among authors: visintin a. J Clin Invest. 1997 Sep 1;100(5):1248-55. doi: 10.1172/JCI119638. J Clin Invest. 1997. PMID: 9276743 Free PMC article.

5

Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review).

Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M, Fonsatti E. Maio M, et al. Among authors: visintin a. Int J Oncol. 1998 Aug;13(2):305-18. doi: 10.3892/ijo.13.2.305. Int J Oncol. 1998. PMID: 9664126 Review.

6

Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR).

Coral S, Sigalotti L, Gasparollo A, Cattarossi I, Visintin A, Cattelan A, Altomonte M, Maio M. Coral S, et al. Among authors: visintin a. J Immunother. 1999 Jan;22(1):16-24. doi: 10.1097/00002371-199901000-00003. J Immunother. 1999. PMID: 9924695

7

Regulation of Toll-like receptors in human monocytes and dendritic cells.

Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Visintin A, et al. J Immunol. 2001 Jan 1;166(1):249-55. doi: 10.4049/jimmunol.166.1.249. J Immunol. 2001. PMID: 11123299

8

Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization.

Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Mazzoni A, et al. Among authors: visintin a. J Clin Invest. 2001 Dec;108(12):1865-73. doi: 10.1172/JCI13930. J Clin Invest. 2001. PMID: 11748270 Free PMC article.

9

CD38 triggers cytotoxic responses in activated human natural killer cells.

Sconocchia G, Titus JA, Mazzoni A, Visintin A, Pericle F, Hicks SW, Malavasi F, Segal DM. Sconocchia G, et al. Among authors: visintin a. Blood. 1999 Dec 1;94(11):3864-71. Blood. 1999. PMID: 10572102 Free article.

10

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Mazzoni A, et al. Among authors: visintin a. J Immunol. 2002 Jan 15;168(2):689-95. doi: 10.4049/jimmunol.168.2.689. J Immunol. 2002. PMID: 11777962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters